Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Rashidkhan Pathan"'
Autor:
Vito Baraka, Abel Nhama, Pedro Aide, Quique Bassat, Agatha David, Samwel Gesase, Jonathan Gwasupika, Sebastian Hachizovu, Geofrey Makenga, Christian Ruchaho Ntizimira, Orikomaba Obunge, Kitoto Antoinette Tshefu, Marc Cousin, Nekoye Otsyula, Rashidkhan Pathan, Céline Risterucci, Guoqin Su, Christine Manyando
Publikováno v:
Malaria Journal, Vol 22, Iss 1, Pp 1-11 (2023)
Abstract Background This study aimed to evaluate the gap between guidelines and local clinical practice for diagnosis and treatment of uncomplicated and severe malaria, the patient characteristics, diagnostic approach, treatment, and compliance to st
Externí odkaz:
https://doaj.org/article/f8c57da348e04d94811c5f69c0a69b8b
Autor:
Teerha Piratvisuth, Piyawat Komolmit, Tawesak Tanwandee, Wattana Sukeepaisarnjaroen, Henry L Y Chan, Mário G Pessôa, Eduardo Fassio, Suzane K Ono, Fernando Bessone, Jorge Daruich, Stefan Zeuzem, Hugo Cheinquer, Rashidkhan Pathan, Yuhong Dong, Aldo Trylesinski
Publikováno v:
PLoS ONE, Vol 8, Iss 2, p e54279 (2013)
The Roadmap concept is a therapeutic framework in chronic hepatitis B for the intensification of nucleoside analogue monotherapy based on early virologic response. The efficacy and safety of this approach applied to telbivudine treatment has not been
Externí odkaz:
https://doaj.org/article/80753a973561437b84b7bcea898690c2
Autor:
Stuart Elborn, Gerhild Angyalosi, Herman Goossens, Felix C. Ringshausen, Michael M. Tunney, Charles S. Haworth, Michael R. Loebinger, Rashidkhan Pathan, Adam T. Hill, James D. Chalmers, Eva Polverino, Harm A.W.M. Tiddens, Francesco Blasi
Publikováno v:
European Respiratory Journal, 57(1):2001451. European Respiratory Society
The European respiratory journal
The European respiratory journal
The study aimed to determine the efficacy of a safe and well-tolerated dose and regimen of tobramycin inhalation powder (TIP) on Pseudomonas aeruginosa sputum density in patients with bronchiectasis.This is a phase II, double-blind, randomised study
Autor:
Stuart Elborn, Michael M. Tunney, Francesco Blasi, Charles S. Haworth, Michael R. Loebinger, Gerhild Angyalosi, Rashidkhan Pathan, Harm A.W.M. Tiddens, Felix C. Ringshausen, Adam T. Hill, Herman Goossens, Eva Polverino, James D. Chalmers
Publikováno v:
Respiratory infections.
Background: This is the first study evaluating 3 different doses and 2 regimens of tobramycin inhalation powder (TIP) that reduces Pseudomonas aeruginosa (Pa) load in patients with bronchiectasis (BE). Methods: A phase II, double-blinded study includ
Autor:
Michael R, Loebinger, Eva, Polverino, James D, Chalmers, Harm A W M, Tiddens, Herman, Goossens, Michael, Tunney, Felix C, Ringshausen, Adam T, Hill, Rashidkhan, Pathan, Gerhild, Angyalosi, Francesco, Blasi, Stuart J, Elborn, Charles S, Haworth
Publikováno v:
The European respiratory journal. 57(1)
The study aimed to determine the efficacy of a safe and well-tolerated dose and regimen of tobramycin inhalation powder (TIP) on
Autor:
Rashidkhan Pathan, Riccardo Utili, Zoe H. Dailiana, Kamal Hamed, Nisichenko Dmitriy, Vassiliki Syriopoulou
Publikováno v:
The Pediatric Infectious Disease Journal
Gram-positive bacteria, especially methicillin-resistant Staphylococcus aureus (MRSA), are known to be common pathogens in children and adolescents in both healthcare and community-associated infections.1–3 Treatment of resistant pathogens includin
Autor:
Snehal Subodhbhai Patel, Amita U. Surana, Falguni Vipul Chaudhary, Shefali Patel, Rummankhan Rashidkhan Pathan, Rehan Naimullah Ansari
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 12, Iss 11, Pp SC04-SC07 (2018)
Introduction: Acute intermittent wheezing illnesses are frequent occurrences in preschool children and need better management strategies. Montelukast, a leukotriene receptor antagonist has potent anti-inflammatory property with rapid onset of action
Autor:
Francesco Menichetti, Georgios N. Dalekos, R. Andrew Seaton, Rashidkhan Pathan, Francisco Nacinovich, Kamal Hamed, Andres Beiras-Fernandez
Publikováno v:
Advances in Therapy
Introduction Daptomycin, a rapid concentration-dependent bactericidal antibiotic, is approved at a dose of 4 mg/kg/day for the treatment of complicated skin and soft tissue infections (cSSTI) and at a dose of 6 mg/kg/day for the treatment of Staphylo
Autor:
JB Sarma, M. Militz, R. A. Seaton, Rashidkhan Pathan, U. Trostmann, K. Malizos, F. Menichetti, J. Gaudias, G. Riccio, Kamal Hamed
Publikováno v:
European Journal of Clinical Microbiology & Infectious Diseases
Osteomyelitis is a serious infection predominantly caused by Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). Orthopaedic device-related infections are complex and require a careful combination of surgical interve
Autor:
Markus Heep, Pierluigi Viale, R. Andrew Seaton, Teresa Santantonio, Rashidkhan Pathan, Enzo Petrelli, Konstantinos N. Malizos, Ricardo L. Chaves, Panagiotis Gargalianos-Kakolyris
Publikováno v:
Journal of Antimicrobial Chemotherapy
BACKGROUND: Osteomyelitis is a complex and heterogeneous group of infections that require surgical and antimicrobial interventions. Because treatment failure or intolerance is common, new treatment options are needed. Daptomycin has broad Gram-positi